You Position: Home > Paper

Research progress of bevacizumab in the treatment of recurrent respiratory papilloma

( views:10, downloads:0 )
Author:
No author available
Journal Title:
International Journal of Otolaryngology-Head and Neck Surgery
Issue:
4
DOI:
10.3760/cma.j.issn.1673-4106.2024.04.005
Key Word:
乳头瘤病毒感染;呼吸道乳头状瘤病毒;复发,再发;贝伐珠单抗

Abstract: 复发性呼吸道乳头状瘤病是一种罕见的呼吸道黏膜疾病,其特征是乳头状瘤在喉部、气管和肺实质等部位反复生长.它主要由6型或11型人乳头瘤病毒感染引起,常表现为声音嘶哑、呼吸困难、慢性咳嗽、喘鸣等,目前尚无治愈办法.贝伐珠单抗可有效抑制血管内皮生长因子与其受体的结合,从而抑制肿瘤细胞的血管生成,近年来在复发性呼吸道乳头状瘤病的辅助治疗中发挥着越来越重要的作用.本文就贝伐珠单抗用于复发性呼吸道乳头状瘤病的辅助治疗进展做一综述.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn
Baidu
map